It’s still early innings for specialty pharma company Knight Therapeutics (Knight Therapeutics Sto... Read More
Stifel GMP analyst Justin Keywood says investors can expect to see Knight Therapeutics (Knight Thera... Read More
With most stocks well off their 12-month highs, there are plenty of potential wins in the market the... Read More
Stifel GMP analyst Justin Keywood likes what he sees so far from Knight Therapeutics (Knight Therape... Read More
Specialty pharma company Knight Therapeutics (Knight Therapeutics Stock Quote, Chart, News TSX:GUD) ... Read More
All’s well with Knight Therapeutics (Knight Therapeutics Stock Quote, Chart, News TSX:GUD) after t... Read More